Jacobs Levy Equity Management, Inc Alector, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Alector, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,230,974 shares of ALEC stock, worth $1.53 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,230,974
Previous 1,322,882
6.95%
Holding current value
$1.53 Million
Previous $1.85 Million
96.71%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ALEC
# of Institutions
159Shares Held
58.1MCall Options Held
614KPut Options Held
223K-
Black Rock Inc. New York, NY9.1MShares$11.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.99MShares$8.67 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.03MShares$7.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$2.94 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$2.71 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $102M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...